# Oral Dosage Form New Animal Drugs; Pyrantel Pamoate Suspension
> **Food and Drug Administration** · Final rule, technical amendment. · Published 2003-09-23 · Effective 2003-09-23 · 68 FR 55199
## Document
- **Document number:** 03-24162
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 68 FR 55199
- **CFR reference:** 21 CFR 520
- **Publication date:** 2003-09-23
- **Effective date:** 2003-09-23
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental abbreviated new animal drug application (ANADA) filed by Phoenix Scientific, Inc. The supplemental ANADA provides for over-the-counter marketing status for pyrantel pamoate suspension, when labeled for oral administration to horses and ponies for the removal and control of certain internal parasites.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2003/09/23/03-24162/oral-dosage-form-new-animal-drugs-pyrantel-pamoate-suspension)
---
*AI Analytics · CC0 1.0*